-
Something wrong with this record ?
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group
K. Aimla, JD. Kowalska, R. Matulionyte, V. Mulabdic, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulos, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, A. Verhaz, D....
Status not-indexed Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2013-03-01
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- Publication type
- Journal Article MeSH
(1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, prophylaxis and treatment of viral hepatitis in PLWH in Central and Eastern Europe (CEE) in 2019 and 2022. (2) Methods: Data was collected through two on-line surveys conducted in 2019 and 2022 among 18 countries of the Euroguidelines in CEE (ECEE) Network Group. (3) Results: In all 18 countries the standard of care was to screen all PLWH for HBV and HCV both years; screening of HAV was routine in 2019 in 54.5% and in 2022 47.4% of clinics. Vaccination of PLWH against HAV was available in 2019 in 16.7%, in 2022 in 22.2% countries. Vaccination against HBV was available routinely and free of charge in 50% of clinics both in 2019 and 2022. In HIV/HBV co-infected the choice of NRTI was tenofovir-based in 94.4% of countries in both years. All clinics that responded had access to direct-acting antivirals (DAAs) but 50% still had limitations for treatment. (4) Conclusions: Although testing for HBV and HCV was good, testing for HAV is insufficient. Vaccination against HBV and especially against HAV has room for improvement; furthermore, HCV treatment access needs to overcome restrictions.
City Clinical Hospital of Infectious Diseases 220002 Minsk Belarus
Clinic for Infectious Diseases Republic of Srpska Banja Luka 78000 Banja Luka Bosnia and Herzegovina
Clinic of the Gromashevsky Institute of Epidemiology and Infectious Diseases 01001 Kyiv Ukraine
Department of Infectious Diseases Tartu University Hospital 50406 Tartu Estonia
Department of Infectology and Geographical Medicine 833 05 Bratislava Slovakia
Infectious Diseases AIDS and Clinical Immunology Research Center 0160 Tbilisi Georgia
Lviv Regional Public Health Center HIV Unit 79000 Lviv Ukraine
National AIDS Center 0041 Yerevan Armenia
National Institute of Infectious Diseases Prof Dr Matei Balș 021105 Bucharest Romania
University Hospital of Infectious Diseases 10000 Zagreb Croatia
Victor Babes Clinical Hospital for Infectious and Tropical Diseases 030303 Bucharest Romania
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009769
- 003
- CZ-PrNML
- 005
- 20230721095451.0
- 007
- ta
- 008
- 230707s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/vaccines11050980 $2 doi
- 035 __
- $a (PubMed)37243084
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Aimla, Kerstin $u Department of Infectious Diseases, Tartu University Hospital, 50406 Tartu, Estonia
- 245 10
- $a Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group / $c K. Aimla, JD. Kowalska, R. Matulionyte, V. Mulabdic, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulos, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, A. Verhaz, D. Gokengin, G. Dragovic, L. Sojak, A. Skrzat-Klapaczyńska, Euroguidelines in Central and Eastern Europe Network Group
- 520 9_
- $a (1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, prophylaxis and treatment of viral hepatitis in PLWH in Central and Eastern Europe (CEE) in 2019 and 2022. (2) Methods: Data was collected through two on-line surveys conducted in 2019 and 2022 among 18 countries of the Euroguidelines in CEE (ECEE) Network Group. (3) Results: In all 18 countries the standard of care was to screen all PLWH for HBV and HCV both years; screening of HAV was routine in 2019 in 54.5% and in 2022 47.4% of clinics. Vaccination of PLWH against HAV was available in 2019 in 16.7%, in 2022 in 22.2% countries. Vaccination against HBV was available routinely and free of charge in 50% of clinics both in 2019 and 2022. In HIV/HBV co-infected the choice of NRTI was tenofovir-based in 94.4% of countries in both years. All clinics that responded had access to direct-acting antivirals (DAAs) but 50% still had limitations for treatment. (4) Conclusions: Although testing for HBV and HCV was good, testing for HAV is insufficient. Vaccination against HBV and especially against HAV has room for improvement; furthermore, HCV treatment access needs to overcome restrictions.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kowalska, Justyna Dominika $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland $1 https://orcid.org/0000000311664462
- 700 1_
- $a Matulionyte, Raimonda $u Department of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, LT-08410 Vilnius, Lithuania
- 700 1_
- $a Mulabdic, Velida $u Clinic for Infectious Diseases, University Clinical Center Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina
- 700 1_
- $a Vassilenko, Anna $u City Clinical Hospital of Infectious Diseases, 220002 Minsk, Belarus $1 https://orcid.org/0000000319072322
- 700 1_
- $a Bolokadze, Natalie $u Infectious Diseases, AIDS and Clinical Immunology Research Center, 0160 Tbilisi, Georgia
- 700 1_
- $a Jilich, David $u Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Faculty Hospital Bulovka, 18000 Prague, Czech Republic
- 700 1_
- $a Antoniak, Sergii $u Clinic of the Gromashevsky Institute of Epidemiology and Infectious Diseases, 01001 Kyiv, Ukraine $1 https://orcid.org/0000000333322762
- 700 1_
- $a Oprea, Cristiana $u Victor Babes Clinical Hospital for Infectious and Tropical Diseases, 030303 Bucharest, Romania
- 700 1_
- $a Balayan, Tatevik $u National AIDS Center, 0041 Yerevan, Armenia
- 700 1_
- $a Harxhi, Arjan $u Department of Infectious Disease, Faculty of Medicine, Medical University of Tirana, 1000 Tirana, Albania $1 https://orcid.org/0000000185187377
- 700 1_
- $a Papadopoulos, Antonios $u HIV Unit, 4th Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece
- 700 1_
- $a Lakatos, Botond $u National Instititue of Hematology and Infectious Diseases, National Center of HIV, 1097 Budapest, Hungary
- 700 1_
- $a Vasylyev, Marta $u Lviv Regional Public Health Center, HIV Unit, 79000 Lviv, Ukraine $1 https://orcid.org/0000000201928009
- 700 1_
- $a Begovac, Josip $u University Hospital of Infectious Diseases, 10000 Zagreb, Croatia $1 https://orcid.org/0000000326414327
- 700 1_
- $a Yancheva, Nina $u Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases, Medical University of Sofia, 1606 Sofia, Bulgaria $1 https://orcid.org/000000020095263X
- 700 1_
- $a Streinu-Cercel, Anca $u National Institute of Infectious Diseases "Prof. Dr. Matei Balș", 021105 Bucharest, Romania
- 700 1_
- $a Verhaz, Antonija $u Clinic for Infectious Diseases Republic of Srpska Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina $1 https://orcid.org/000000025558976X
- 700 1_
- $a Gokengin, Deniz $u Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Ege University, 35100 Izmir, Turkey $1 https://orcid.org/0000000307042302
- 700 1_
- $a Dragovic, Gordana $u Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia $1 https://orcid.org/0000000204380309
- 700 1_
- $a Sojak, Lubomir $u Department of Infectology and Geographical Medicine, 833 05 Bratislava, Slovakia $1 https://orcid.org/0000000187450845
- 700 1_
- $a Skrzat-Klapaczyńska, Agata $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland $1 https://orcid.org/0000000263675633
- 710 2_
- $a Euroguidelines in Central and Eastern Europe Network Group
- 773 0_
- $w MED00200686 $t Vaccines $x 2076-393X $g Roč. 11, č. 5 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37243084 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095444 $b ABA008
- 999 __
- $a ok $b bmc $g 1958496 $s 1196033
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 11 $c 5 $e 20230514 $i 2076-393X $m Vaccines $n Vaccines (Basel) $x MED00200686
- LZP __
- $a Pubmed-20230707
